]>
IRCT20100127003210N23 IRCT 2021-09-01 Shahid Beheshti University of Medical Sciences Evaluation and comparison of side effects of Pregabalin and Gabapentin in patients with Psychiatric disorders. Evaluation and comparison of side effects of Pregabalin and Gabapentin in patients with Psychiatric disorders. 2021-08-13 anticipated 60 Complete https://irct.ir/trial/43837 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Screening. 4 Condition 1: Anxiety disorder. Condition 2: Depressive disorder. Intervention 1: First intervention group: The first group will receive 75 to 150 mg of oral pregabalin per day. Intervention 2: Second intervention group: Patients in this group will receive 100 to 600 mg of oral gabapentin per day. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is After analyzing the results, we decide to publish a related article.
public Dr. Maria Tavakoli Ardakani
Shahid Beheshti School of Pharmacy, Niayesh Highway, Valiasr Ave, Tehran, Iran
Tehran Iran (Islamic Republic of) 1991953381 +98 21 8820 0118 Mariatavakoli@sbmu.ac.ir Shahid Beheshti University of Medical Sciences scientific Dr. Maria Tavakoli Ardakani
Shahid Beheshti School of Pharmacy, Hashemi Rafsanjani Highway , Valiasr St.
Tehran Iran (Islamic Republic of) 1991953381 +98 21 8820 0118 Mariatavakoli@sbmu.ac.ir Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) 18 to 65 years old. Suffering from depression or anxiety. Taking Sertraline (50-100mg) or Citalopram (20-40mg) or Escitalopram (10mg). Consent to enter the research. Be married. 18 years 65 years Both Refusing to fill the questionnaire. Getting divorced or reaching menopause Taking medications other than those listed. Pregnancy or lactation. Having substance abuse during the study. Being allergic to Pregabalin or Gabapentin. F06.4 F06.32 Anxiety disorder due to known physiological condition Mood disorder due to known physiological condition with major depressive-like episode Treatment - Drugs Treatment - Drugs First intervention group: The first group will receive 75 to 150 mg of oral pregabalin per day. Second intervention group: Patients in this group will receive 100 to 600 mg of oral gabapentin per day. Sexual Dysfunctions. Timepoint: One Month. Method of measurement: The International Index of Erectile function Questionnaire; The Female Sexual Function Index Questionnaire. Drowsiness. Timepoint: One Month. Method of measurement: Questionnaire. Dizziness. Timepoint: One Month. Method of measurement: Questionnaire. Shahid Beheshti University of Medical Sciences Approved 2019-11-10 Ethics committee of Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences The SBMU school of pharmacy, Valiasr St., Niayesh cross section, Tehran Tehran Tehran Iran (Islamic Republic of)